APOBEC-2の結晶構造とデアミナーゼに対する機能的影響は,AIDの助けとなりました
Courtney Prochnow1, Ronda Bransteitter, Michael G Klein
1Molecular and Computational Biology, University of Southern California Los Angeles, California 90089, USA.
Nature
|December 26, 2006
まとめ
アポリポプロテインBメッセンジャーRNA編集酵素触媒ポリペプチド2 (APOBEC-2) の結晶構造は,独特の棒状のテトラメールを明らかにしています. この構造は,活性化誘発型シチジンデアミナーゼのような関連タンパク質の変異が,抗体の成熟を損なう方法についての洞察を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 分子生物学は分子生物学である.
背景:
- APOBEC-2 (APO2) は,mRNAと単一鎖DNAをデマイニングすることが知られているAPOBECファミリーの一部です.
- APOBECタンパク質は,抗体生成 (AID) と抗ウイルス防御 (APOBEC-3) を含む多様な生物学的機能を果たします.
研究 の 目的:
- APOBEC-2 (APO2) の結晶構造を決定する.
- APO2のテトラメリック形成の構造的基礎と,APOBECファミリー機能への影響を理解する.
主な方法:
- APO2の構造を決定するX線結晶学.
- 構造に基づく予測は,配列の同位性により,活性化誘発型シチジンデアミナーゼ (AID) でテストされました.
主要な成果:
- APO2は,サイチジンデアミナーゼの正方形テトレメアと異なる,独特の棒状のテトレメアを形成する.
- APO2の単体構造は,2つの長いアルファヘリクスを有しており,ヘッドツーヘッドのダイマー相互作用を容易にし,棒状のテトラメールを形成します.
- APO2構造から予測されるAIDのオリゴメリゼーションと基板へのアクセスに影響する突然変異は,そのデアミネーション活動を低下させた.
結論:
- APO2の構造は,APOBECファミリー内の新しい四重構造組成機構を明らかにしています.
- APO2の構造を理解することは,AIDの変異がハイパー-IgM-2症候群と欠陥抗体の成熟につながる方法を解釈するための枠組みを提供します.
さらに関連する動画
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13:35Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
関連する概念動画
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
RNA Editing
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
